Skip to main content

Table 2 Clinical characteristics of patients for the two cohorts

From: DCE-MRI is more sensitive than IVIM-DWI for assessing anti-angiogenic treatment-induced changes in colorectal liver metastases

Main cohort (N=25): phase II clinical trial patients; DCE-MRI vs. IVIM-DWI
Disease liver metastases from colorectal cancer
Primary cancer colorectal (all patients)
Treatment oral anti-angiogenic drug (Regorafenib) administered daily
Sex [Female/Male] 9/16
Age in years (mean ± SD; range) 64.4 ± 10.7; 44 - 86
Lesion volume in mL (mean ± SD; range) 45.8 ± 60.1; 2.2 - 265.1
Repeatability cohort (N=5): clinical patients; IVIM-DWI
Disease liver metastases from gastrointestinal cancer
Primary cancer 3 colorectal, 1 stomach, 1 caecal
Treatment not relevant
Sex [Female/Male] 2/3
Age in years (mean ± SD, range) 61.0 ± 11.6; 50 - 80
Lesion volume in mL (mean ± SD, range) 91.9 ± 164.5; 4.1 - 385.6
  1. SD=standard deviation